A multicenter randomized, double-blinded placebo-controlled phase 2 trial to evaluate safety and efficacy of ilofotase alfa in patients at risk for kidney injury following open heart surgery. (link.springer.com)

Authors: Mourisse L … Pickkers P Journal: Intensive Care Medicine Published: 2026-09-21 DOI: https://doi.org/10.1007/s00134-026-08596-y